Company profile
CNS Pharmaceuticals, Inc.
NASDAQ:CNSPBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04762069 | phase2 | active_not_recruiting | 2021-05-18 | 2026-04-27 | CNS Pharmaceuticals, Inc. | A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme |
FDA applications (0)
No records yet.